Palvella Therapeutics (PVLA) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.21
-1.05
-0.9
-0.74

Details

Expected EPS
-0.935
Actual EPS
-1.2
Surprise EPS
-0.26
Surprise Percent
-28.34%

Description

⁨Palvella Therapeutics⁩ (⁦PVLA⁩) has reported earnings of ⁦-1.2⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts